Is Human Oxoguanine Glycosylase 1 Genetic Variant Successful even on Oral Squamous Cell Carcinoma?

dc.contributor.author	Aydemir, L.
dc.contributor.author	Bireller, E.S.
dc.contributor.author	Avci, H.
dc.contributor.author	Boy, Metin, Z.
dc.contributor.author	Deger, K.
dc.contributor.author	Unur, M.
dc.contributor.author	Cakmakoglu, B.
dc.date.accessioned	2021-12-21T08:41:15Z
dc.date.available	2021-12-21T08:41:15Z
dc.date.issued	2017
dc.identifier.issn	10152008
dc.identifier.uri	https://doi.org/10.1159/000466702
dc.identifier.uri	http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1371
dc.description.abstract	Oral squamous cell carcinoma (OSCC) is one of the most widespread cancer types that arise from different sites of oral cavity and has a 5-year survival rate. This study is aimed at investigating the human oxoguanine glycosylase 1 (hOGG1)-Ser326Cys and APE
dc.language.iso	English
dc.publisher	S. Karger AG
dc.rights	All Open Access, Bronze
dc.title	Is Human Oxoguanine Glycosylase 1 Genetic Variant Successful even on Oral Squamous Cell Carcinoma?
dc.type	Article
dc.relation.journal	Pathobiology
dc.identifier.issue	4
dc.identifier.startpage	223
dc.identifier.endpage	228
dc.identifier.volume	84
dc.identifier.doi	10.1159/000466702
dc.relation.issue	4
dc.relation.volume	84

Files in this item

Files	Size	Format	View
There are no files associated with this item.